Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma
Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This trial will compare the efficacy of docetaxel/carboplatin versus docetaxel/liposomal
doxorubicin in pretreated patients with advanced ovarian carcinoma and treatment
free-interval of at least six months